Pharmaceutical composition containing prostaglandin
US8697751B2 · kind B2 · utility
4Cited by
11References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2011 |
| Grant date | Apr 15, 2014 |
| Priority date | — |
| Expiry date | Aug 10, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An object of the present invention is to provide a stable aqueous pharmaceutical composition which suppresses degradation of prostaglandin F2α in a preparation containing prostaglandin F2α. The object was attained by formulating a prostaglandin F2α derivative into an oil-in-water emulsion together with an oil, for example, medium chain fatty acid triglyceride, a water-soluble polymer and water.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.